Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype

K. Radig, C. Hackel, J. Herting, Yoshinao Oda, U. Mittler, W. Neumann, A. Roessner

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The development of chemoresistance is one of the major clinical problems in the therapy of malignant bone tumors in childhood. The expression of membrane-bound P-glycoprotein turned out to be an essential factor in the evidence of resistant tumor cells. To investigate the significance of multidrug resistance in the prognosis of highly malignant osteosarcomas, the immunohistologic expression of P-glycoprotein was investigated in the tumor tissue of 52 patients under special consideration of the histologic subtype. The data were compared with the histologic regression grade in the resection specimen and correlated with clinical data. Formalin-fixed, paraffin-embedded tissue and, additionally, fresh frozen material taken from the primary biopsy were stained using monoclonal antibody JSB1. 29 (55%) of the tumors investigated were P-glycoprotein positive. Considering the response to chemotherapy, no conclusion could be drawn regarding P-glycoprotein expression, regression grade in the resection specimens, and the clinical follow-up. P-glycoprotein was detected in only 52% of the non-responders. A positive reaction was also evidenced in 59% of the patients with high chemosensitivity. A comparison of the histologic subtypes yielded a significant result in the chondroblastic osteosarcomas. 11 of 12 cases showed a strong expression of P-glycoprotein. Most of the cases were non-responders, and using Kaplan-Meier live tables, an unfavorable clinical outcome could be demonstrated. Possibly, chondroblastic tumors have a special position among osteosarcomas because of their differentiation.

Original languageEnglish
Pages (from-to)139-145
Number of pages7
JournalGeneral and Diagnostic Pathology
Volume142
Issue number3-4
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

P-Glycoprotein
Osteosarcoma
Neoplasms
Multiple Drug Resistance
Paraffin
Formaldehyde
Monoclonal Antibodies
Biopsy
Bone and Bones
Drug Therapy
Membranes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Radig, K., Hackel, C., Herting, J., Oda, Y., Mittler, U., Neumann, W., & Roessner, A. (1997). Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. General and Diagnostic Pathology, 142(3-4), 139-145.

Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. / Radig, K.; Hackel, C.; Herting, J.; Oda, Yoshinao; Mittler, U.; Neumann, W.; Roessner, A.

In: General and Diagnostic Pathology, Vol. 142, No. 3-4, 1997, p. 139-145.

Research output: Contribution to journalArticle

Radig, K, Hackel, C, Herting, J, Oda, Y, Mittler, U, Neumann, W & Roessner, A 1997, 'Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype', General and Diagnostic Pathology, vol. 142, no. 3-4, pp. 139-145.
Radig, K. ; Hackel, C. ; Herting, J. ; Oda, Yoshinao ; Mittler, U. ; Neumann, W. ; Roessner, A. / Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. In: General and Diagnostic Pathology. 1997 ; Vol. 142, No. 3-4. pp. 139-145.
@article{1aa4ae91ae8d43129a7ab0980ee9c897,
title = "Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype",
abstract = "The development of chemoresistance is one of the major clinical problems in the therapy of malignant bone tumors in childhood. The expression of membrane-bound P-glycoprotein turned out to be an essential factor in the evidence of resistant tumor cells. To investigate the significance of multidrug resistance in the prognosis of highly malignant osteosarcomas, the immunohistologic expression of P-glycoprotein was investigated in the tumor tissue of 52 patients under special consideration of the histologic subtype. The data were compared with the histologic regression grade in the resection specimen and correlated with clinical data. Formalin-fixed, paraffin-embedded tissue and, additionally, fresh frozen material taken from the primary biopsy were stained using monoclonal antibody JSB1. 29 (55{\%}) of the tumors investigated were P-glycoprotein positive. Considering the response to chemotherapy, no conclusion could be drawn regarding P-glycoprotein expression, regression grade in the resection specimens, and the clinical follow-up. P-glycoprotein was detected in only 52{\%} of the non-responders. A positive reaction was also evidenced in 59{\%} of the patients with high chemosensitivity. A comparison of the histologic subtypes yielded a significant result in the chondroblastic osteosarcomas. 11 of 12 cases showed a strong expression of P-glycoprotein. Most of the cases were non-responders, and using Kaplan-Meier live tables, an unfavorable clinical outcome could be demonstrated. Possibly, chondroblastic tumors have a special position among osteosarcomas because of their differentiation.",
author = "K. Radig and C. Hackel and J. Herting and Yoshinao Oda and U. Mittler and W. Neumann and A. Roessner",
year = "1997",
language = "English",
volume = "142",
pages = "139--145",
journal = "General and Diagnostic Pathology",
issn = "0947-823X",
publisher = "Gustav Fischer Verlag",
number = "3-4",

}

TY - JOUR

T1 - Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype

AU - Radig, K.

AU - Hackel, C.

AU - Herting, J.

AU - Oda, Yoshinao

AU - Mittler, U.

AU - Neumann, W.

AU - Roessner, A.

PY - 1997

Y1 - 1997

N2 - The development of chemoresistance is one of the major clinical problems in the therapy of malignant bone tumors in childhood. The expression of membrane-bound P-glycoprotein turned out to be an essential factor in the evidence of resistant tumor cells. To investigate the significance of multidrug resistance in the prognosis of highly malignant osteosarcomas, the immunohistologic expression of P-glycoprotein was investigated in the tumor tissue of 52 patients under special consideration of the histologic subtype. The data were compared with the histologic regression grade in the resection specimen and correlated with clinical data. Formalin-fixed, paraffin-embedded tissue and, additionally, fresh frozen material taken from the primary biopsy were stained using monoclonal antibody JSB1. 29 (55%) of the tumors investigated were P-glycoprotein positive. Considering the response to chemotherapy, no conclusion could be drawn regarding P-glycoprotein expression, regression grade in the resection specimens, and the clinical follow-up. P-glycoprotein was detected in only 52% of the non-responders. A positive reaction was also evidenced in 59% of the patients with high chemosensitivity. A comparison of the histologic subtypes yielded a significant result in the chondroblastic osteosarcomas. 11 of 12 cases showed a strong expression of P-glycoprotein. Most of the cases were non-responders, and using Kaplan-Meier live tables, an unfavorable clinical outcome could be demonstrated. Possibly, chondroblastic tumors have a special position among osteosarcomas because of their differentiation.

AB - The development of chemoresistance is one of the major clinical problems in the therapy of malignant bone tumors in childhood. The expression of membrane-bound P-glycoprotein turned out to be an essential factor in the evidence of resistant tumor cells. To investigate the significance of multidrug resistance in the prognosis of highly malignant osteosarcomas, the immunohistologic expression of P-glycoprotein was investigated in the tumor tissue of 52 patients under special consideration of the histologic subtype. The data were compared with the histologic regression grade in the resection specimen and correlated with clinical data. Formalin-fixed, paraffin-embedded tissue and, additionally, fresh frozen material taken from the primary biopsy were stained using monoclonal antibody JSB1. 29 (55%) of the tumors investigated were P-glycoprotein positive. Considering the response to chemotherapy, no conclusion could be drawn regarding P-glycoprotein expression, regression grade in the resection specimens, and the clinical follow-up. P-glycoprotein was detected in only 52% of the non-responders. A positive reaction was also evidenced in 59% of the patients with high chemosensitivity. A comparison of the histologic subtypes yielded a significant result in the chondroblastic osteosarcomas. 11 of 12 cases showed a strong expression of P-glycoprotein. Most of the cases were non-responders, and using Kaplan-Meier live tables, an unfavorable clinical outcome could be demonstrated. Possibly, chondroblastic tumors have a special position among osteosarcomas because of their differentiation.

UR - http://www.scopus.com/inward/record.url?scp=0031058587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031058587&partnerID=8YFLogxK

M3 - Article

VL - 142

SP - 139

EP - 145

JO - General and Diagnostic Pathology

JF - General and Diagnostic Pathology

SN - 0947-823X

IS - 3-4

ER -